Bausch Health Companies (BHC) Research & Development (2016 - 2025)
Historic Research & Development for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $166.0 million.
- Bausch Health Companies' Research & Development rose 1369.86% to $166.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $631.0 million, marking a year-over-year increase of 429.75%. This contributed to the annual value of $616.0 million for FY2024, which is 198.68% up from last year.
- Per Bausch Health Companies' latest filing, its Research & Development stood at $166.0 million for Q3 2025, which was up 1369.86% from $159.0 million recorded in Q2 2025.
- In the past 5 years, Bausch Health Companies' Research & Development registered a high of $166.0 million during Q3 2025, and its lowest value of $112.0 million during Q1 2021.
- Its 5-year average for Research & Development is $141.2 million, with a median of $143.0 million in 2023.
- As far as peak fluctuations go, Bausch Health Companies' Research & Development plummeted by 819.67% in 2021, and later skyrocketed by 2283.46% in 2023.
- Quarter analysis of 5 years shows Bausch Health Companies' Research & Development stood at $117.0 million in 2021, then rose by 21.37% to $142.0 million in 2022, then increased by 7.04% to $152.0 million in 2023, then rose by 7.24% to $163.0 million in 2024, then rose by 1.84% to $166.0 million in 2025.
- Its Research & Development stands at $166.0 million for Q3 2025, versus $159.0 million for Q2 2025 and $143.0 million for Q1 2025.